Treatment outcomes associated with multidrug-resistant tuberculosis

Treatment outcomes associated with multidrug-resistant tuberculosis

Background: Developing countries like India are heavily burdened with multidrug resistant tuberculosis (MDR-TB). Materials and Methods: A retrospective study was carried out at the directly observed treatment short course chemotherapy plus site in our tertiary care center (All India Institute of Med...

Full description

Bibliographic Details
Main Authors:	Nitin Gupta, Pankaj Jorwal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Journal of Global Infectious Diseases
Subjects:	Directly observed treatment short course chemotherapy-plus Programmatic Management of Drug-resistant Tuberculosis Mycobacterium tuberculosis
Online Access:	http://www.jgid.org/article.asp?issn=0974-777X;year=2018;volume=10;issue=3;spage=125;epage=128;aulast=Gupta

Similar Items

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
by: Zarir F Udwadia, et al.
Published: (2016-01-01)

Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan
by: Chih-Bin Lin, et al.
Published: (2019-01-01)

Programmatic challenges in managing multidrug-resistant tuberculosis in Malawi
by: Loveness Charlie, et al.
Published: (2021-01-01)

SHORT-TERM CHEMOTHERAPY REGIMEN OF MULTIDRUG-RESISTANT TUBERCULOSIS IN THE KYRGYZ REPUBLIC
by: E.V. ZHDANOVA, et al.
Published: (2018-08-01)

First-line anti-tubercular drug resistance of mycobacterial strains from re-treatment cases that were smear-positive at 4 th month onwards under the Revised National Tuberculosis Control Program
by: Surajit Lahiri, et al.
Published: (2015-01-01)

Evaluation of treatment outcome and adverse drug reaction of directly observed treatment (DOT) plus regimen in multidrug-resistant tuberculosis (MDR-TB) patients at district tuberculosis centre Rajkot
by: Kiran Gordhanbhai Piparva, et al.
Published: (2018-01-01)

A study of rifampicin and isoniazid resistance in pulmonary tuberculosis patients with various radiological presentations at a designated microscopy center
by: Roshan Lal, et al.
Published: (2023-01-01)

Rifampicin-induced Pancytopenia in Pulmonary Tuberculosis Patient: A Rare Presentation
by: Yashika Bansal, et al.
Published: (2024-03-01)

Selecting an appropriate all-oral short-course regimen for patients with multidrug-resistant or pre-extensive drug-resistant tuberculosis in China: A multicenter prospective cohort study
by: Liang Fu, et al.
Published: (2023-10-01)

Pattern of initial drug resistance and its impact on short course chemotherapy of pulmonary tuberculosis
by: Rai S, et al.
Published: (2007-01-01)

Knowledge about tuberculosis, treatment adherence and outcome among ambulatory patients with drug-sensitive tuberculosis in two directly-observed treatment centres in Southwest Nigeria
by: Rasaq Adisa, et al.
Published: (2021-04-01)

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis
by: Russell R. Kempker, et al.
Published: (2015-06-01)

Knowledge of tuberculosis management using directly observed treatment short course therapy among final year medical students in South Western Nigeria
by: Olarewaju Sunday Olakunle, et al.
Published: (2014-05-01)

Multidrug-Resistant Tuberculosis, People’s Republic of China, 2007–2009
by: Guang Xue He, et al.
Published: (2011-10-01)

A Case of Immune Thrombocytopenic Purpura Secondary to Pulmonary Tuberculosis
by: Sameer Panda, et al.
Published: (2016-10-01)

High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
by: Elisabeth Sanchez-Padilla, et al.
Published: (2012-01-01)

The organizational challenges in the management of the revised national tuberculosis control program of India: an overview
by: Sankalp Yadav, et al.
Published: (2020-07-01)

Trend of tuberculosis cases under directly observed treatment, short-course strategy in Tabriz, Iran, from 2001 to 2011
by: Zhila Khamnian, et al.
Published: (2016-02-01)

Metabolic Profiles of Clinical Isolates of Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis: A Metabolomics-Based Study
by: Wang L, et al.
Published: (2023-05-01)

Concomitant Multidrug-resistant Pulmonary Tuberculosis and Susceptible Tuberculous Meningitis
by: Christine Bernard, et al.
Published: (2014-03-01)

Chemotherapeutic Interventions Against Tuberculosis
by: Neeraj Shakya, et al.
Published: (2012-06-01)

Scrofula Caused by Multidrug-Resistant Tuberculosis
by: Bárbara Pedro, et al.
Published: (2020-01-01)

Determinanet of the survival pattern of tuberculosis patients treated under directly observed treatment short course at Pawe Hospital, Ethiopia
by: Tsehay Haile, et al.
Published: (2021-01-01)

Mapping the pattern and trends of extrapulmonary tuberculosis
by: S Rama Prakasha, et al.
Published: (2013-01-01)

Revised National Tuberculosis Control Program regimens with and without directly observed treatment, short-course: A comparative study of therapeutic cure rate and adverse reactions
by: Rengaraj Sivaraj, et al.
Published: (2014-01-01)

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada
by: Kamila Romanowski, et al.
Published: (2017-09-01)

ANTITUBERCULOSIS DRUG ALLERGY IN PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: B.B. MAYKANAEV, et al.
Published: (2021-06-01)

Noncompliance to directly observed treatment short course in Mulshi block, Pune district
by: Prasad D Pore, et al.
Published: (2020-01-01)

Client satisfaction and its correlates of directly observed treatment short course therapy in a tuberculosis unit of Bankura, West Bengal
by: Sumana Samanta, et al.
Published: (2019-01-01)

Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
by: Suzanne M. Hingley-Wilson, et al.
Published: (2013-07-01)

The Study of the Possible Program-related Factors Contributing to Drug Resistance in Tuberculosis Patients
by: Hareesh Pathak, et al.
Published: (2023-06-01)

Treatment outcomes and influencing factors on patients with Pulmonary Tuberculosis: a retrospective study
by: Jamshid Ayatollahi, et al.
Published: (2021-02-01)

Distinguishing Nontuberculous Mycobacteria from Multidrug-Resistant Mycobacterium tuberculosis, China
by: Kaijin Xu, et al.
Published: (2014-06-01)

EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE
by: I. A. Morozov, et al.
Published: (2016-11-01)

Treatment outcomes of tuberculosis among new smear-positive and retreatment cases: a retrospective study in two Egyptian governorates
by: Fawzy El Emeiry, et al.
Published: (2019-01-01)

Five-years experiences of the revised national tuberculosis control programme in northern part of Kolkata, India
by: Pandit Sudipta, et al.
Published: (2009-01-01)

The effect of a mhealth intervention on anti-tuberculosis medication adherence in Delhi, India: A quasi-experimental study
by: Sahadev Santra, et al.
Published: (2021-01-01)

Molecular determinants of multidrug-resistant tuberculosis in Sierra Leone
by: Harriet N. A. Blankson, et al.
Published: (2024-03-01)

Genotypic analysis of multidrug-resistant tuberculosis isolates from extra pulmonary tuberculosis cases in tertiary care centers in Northern India
by: Anand K Maurya, et al.
Published: (2016-01-01)

Tuberculosis in Upper and Lower Egypt before and after directly observed treatment short-course strategy: a multi-governorate study
by: Medhat F. Negm, et al.
Published: (2020-01-01)